Neurochemical Alterations in Social Anxiety Disorder (SAD): A Systematic Review of Proton Magnetic Resonance Spectroscopic Studies
- PMID: 35563145
- PMCID: PMC9105768
- DOI: 10.3390/ijms23094754
Neurochemical Alterations in Social Anxiety Disorder (SAD): A Systematic Review of Proton Magnetic Resonance Spectroscopic Studies
Abstract
(1) Objective: Considering that current knowledge of mechanisms involved in the molecular pathogenesis of Social Anxiety Disorder (SAD) is limited, we conducted a systematic review to evaluate cumulative data obtained by Proton Magnetic Resonance Spectroscopic (1H MRS) studies. (2) Methods: A computer-based literature search of Medline, EMBASE, PsycInfo, and ProQuest was performed. Only cross-sectional studies using 1H MRS techniques in participants with SAD and healthy controls (HCs) were selected. (3) Results: The search generated eight studies. The results indicated regional abnormalities in the 'fear neurocircuitry' in patients with SAD. The implicated regions included the anterior cingulate cortex (ACC), dorsomedial prefrontal cortex (dmPFC), dorsolateral prefrontal cortex (dlPFC), insula, occipital cortex (OC), as well as the subcortical regions, including the thalamus, caudate, and the putamen. (4) Conclusions: The evidence derived from eight studies suggests that possible pathophysiological mechanisms of SAD include impairments in the integrity and function of neurons and glial cells, including disturbances in energy metabolism, maintenance of phospholipid membranes, dysregulations of second messenger systems, and excitatory/inhibitory neurocircuitry. Conducting more cross-sectional studies with larger sample sizes is warranted given the limited evidence in this area of research.
Keywords: Nuclear Magnetic Resonance; Proton Magnetic Resonance Spectroscopy; Social Anxiety Disorder; Social Phobia; neurochemicals; neurometabolites; neurotransmitters; systematic review.
Conflict of interest statement
Bernard Le Foll has obtained funding from Pfizer (GRAND Awards, including salary support) for investigator-initiated projects. Le Foll has some in-kind donations of cannabis products from Aurora and medication donations from Pfizer and Bioprojet and was provided a coil for the TMS Study from Brainsway. Le Foll has obtained industry funding from Canopy (through research grants handled by CAMH and the University of Toronto), Bioprojet, ACS, and Alkermes. Moreover, Le Foll has received in-kind donations of nabiximols from GW Pharma for past studies funded by CIHR and NIH. He has been consultant for Shionogi and participated in an Advisory Board Meeting for Indivior. Bernard Le Foll is also supported by CAMH by a Clinician-Scientist Award from the Department of Family and Community Medicine at the University of Toronto, and he currently is Addiction Psychiatry Chair at the Department of Psychiatry of the University of Toronto. Furthermore, he is supported by the Waypoint Centre for Mental Health. There are no conflicts of interest related to current work.
Figures



Similar articles
-
A Proton Magnetic Resonance Spectroscopy (1H MRS) Pilot Study Revealing Altered Glutamatergic and Gamma-Aminobutyric Acid (GABA)ergic Neurotransmission in Social Anxiety Disorder (SAD).Int J Mol Sci. 2025 Jul 18;26(14):6915. doi: 10.3390/ijms26146915. Int J Mol Sci. 2025. PMID: 40725163 Free PMC article.
-
Neurochemical changes in patients with chronic low back pain detected by proton magnetic resonance spectroscopy: A systematic review.Neuroimage Clin. 2016 Nov 24;13:33-38. doi: 10.1016/j.nicl.2016.11.006. eCollection 2017. Neuroimage Clin. 2016. PMID: 27920977 Free PMC article.
-
Resting-state functional connectivity in anxiety disorders: a multicenter fMRI study.Mol Psychiatry. 2025 Apr;30(4):1548-1557. doi: 10.1038/s41380-024-02768-2. Epub 2024 Oct 4. Mol Psychiatry. 2025. PMID: 39367057 Free PMC article.
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
Resting-state neuroimaging in social anxiety disorder: a systematic review.Mol Psychiatry. 2022 Jan;27(1):164-179. doi: 10.1038/s41380-021-01154-6. Epub 2021 May 25. Mol Psychiatry. 2022. PMID: 34035474
Cited by
-
A Proton Magnetic Resonance Spectroscopy (1H MRS) Pilot Study Revealing Altered Glutamatergic and Gamma-Aminobutyric Acid (GABA)ergic Neurotransmission in Social Anxiety Disorder (SAD).Int J Mol Sci. 2025 Jul 18;26(14):6915. doi: 10.3390/ijms26146915. Int J Mol Sci. 2025. PMID: 40725163 Free PMC article.
-
Comparative Analysis of High-Frequency and Low-Frequency Transcutaneous Electrical Stimulation of the Right Median Nerve in the Regression of Clinical and Neurophysiological Manifestations of Generalized Anxiety Disorder.J Clin Med. 2024 May 21;13(11):3026. doi: 10.3390/jcm13113026. J Clin Med. 2024. PMID: 38892737 Free PMC article.
-
The "Asthma-Polycystic Ovary Overlap Syndrome" and the Therapeutic Role of Myo-Inositol.Int J Mol Sci. 2023 Apr 9;24(8):6959. doi: 10.3390/ijms24086959. Int J Mol Sci. 2023. PMID: 37108123 Free PMC article. Review.
References
-
- Stein D.J., Lim C.C.W., Roest A.M., de Jonge P., Aguilar-Gaxiola S., Al-Hamzawi A., Alonso J., Benjet C., Bromet E.J., Bruffaerts R., et al. Collaborators, WHOWMHS, The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med. 2017;15:143. doi: 10.1186/s12916-017-0889-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources